The European Commission recently adopted its first-ever measures under the International Procurement Instrument Regulation (IPI), restricting Chinese access to the EU public procurement market for medical devices. In this client alert, we take a closer look at the IPI and the measures that the Commission decided to adopt with regard to China, and we consider how the Commission is likely to use the IPI in the future.
Click here to continue reading the full version of this alert.